/CYH

Community Health Systems Inc

CYH

$2.92USD↑+1.04%+0.03 today

MARKET CAP

411.7M

P/E (TTM)

4.9x

FWD P/E

—

DAY RANGE

$3 – $3

52W RANGE

$2

$4

AI Summary

Stalk

TrimMedium

In a Stage 4 decline with confirmed lower highs and lower lows, CYH’s medium-term bias is bearish absent mean-reversion eligibility. The recent bounce into a cluster of falling EMAs and overhead 50/200 DMAs appears corrective. Execution should be deferred until price meets and rejects the dynamic resistance zone. A failure to reclaim that area will offer a sell entry, while a sustained break above would invalidate the bearish posture.

↑Over 40 ASCs driving outpatient growth and incremental revenue
↑Same-store net revenue rose 2.4% YoY from state-directed payment programs
↓Net revenue fell 9.8% YoY to $2.82 B in Q2 2026 due to divestitures and uninsured patient mix

Full analysis →

Buying

4

institutions

Selling

6

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	10.93 M	36.51 M	+1.13 M	+26.7%	0.00%
EP Eversept Partners, LP Q2 2026	SELL	7.86 M	26.27 M	+-812.71 K	+3.0%	1.36%
AC Aqr Capital Management LLC Q2 2026	BUY	2.29 M	7.65 M	+980.08 K	+98.5%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	1.16 M	3.87 M	+429.39 K	+80.4%	0.00%
MM Millennium Management LLC Q2 2026	SELL	759.46 K	2.54 M	+-326.45 K	-20.6%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	54.61 K	185.12 K	+-8.51 K	+2.2%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUY	27.28 K	91.12 K	+4.84 K	+38.1%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	452.00	1.51 K	+-1.19 K	-68.6%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-242.51 K	-100.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-32.35 K	-100.0%	0.00%